Location: Home
  • search
  • go
  • Relate News
  • 2/12/2025The Drug Industry Is Having Its Own DeepSeek Moment (WSJ)
  • 2/7/2025Rapid Trials Prompt Deals Rush for Chinese ‘Super Me-Too’ Drugs (FT)
  • 2/7/2025AstraZeneca Reports Strong 2024 Performance Amid China Sales Decline a...
  • 1/21/2025China's Biopharma R&D Expands Global Influence in 2024
  • 1/15/2025Evolving innovation strategies in China for multinational companies (A...
  • 1/14/2025NHSA Hosts Roundtable on Supporting Innovative Drug Development
  • 1/6/2025State Council Issues New Policy Document on Deepens Reform to Strength...
  • 12/30/20242025 Forecast: What Can AstraZeneca's China Probes Teach Other Biophar...
  • 12/27/2024Review of China's Hospital Drug Market: Strong Competition Amid Slight...
  • 12/24/2024State Council Moves to Advance Pharma Reforms and Regulatory Streamlin...
  • 12/12/2024Shanghai Unveils RMB10 Billion Biopharma M&A Fund to Drive Industry Gr...
  • 12/12/2024Chinese Generic Drug Market Expected to Rise at 10.70% CAGR During 202...
  • 12/10/2024The New Draft Administrative Measures For Management Of Medical Repres...
  • 12/5/20242025 Trends Buoying Boom Phase in APAC (Biospectrum)
  • 12/5/2024Big Pharma Doubles Down on China (The Wire China)
  • 12/3/2024Big Pharma's Bet on China Biotech Is a Rare Trade Bright Spot (Bloomb...
  • 12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
  • 12/3/2024NH DB6: Global and Chinese Consumer Healthcare Market: MAT Q2/2024 Tr...
  • 11/28/2024NMPA Solicits Public Comments on the Provisions for the Record Filing ...
  • 11/21/2024RDPAC Reinforces Strategic Commitment to China's Pharmaceutical Market
  • 11/20/2024Probe of AstraZeneca Executive in China Raises Questions About Company...
  • 11/18/2024New Report on China's Biopharma Revolution: A Decade of Progress and t...
  • 11/15/2024NMPA Issues the Interim Rules on Designated Domestic Representatives f...
  • 11/14/2024Q3/2024 Performance of Leading MNCs in China: AZ Overtakes MSD as Nova...
  • 11/14/2024Passage to Asia: Early Access for Innovative Therapies (PharmExec)
  • 11/14/2024China on the Move: New Level of Opening up in Health Care Sector (NLR)
  • 11/12/2024Trump Presidency to Test Public Trust in Big Pharma (SWI)
  • 11/11/2024Trump's Trade Tango Returns: Will China's Biotech Dance Through Anothe...
  • 11/7/2024A Share-Listed Pharma Companies Report Solid Performance in Q3/2024
  • 11/6/2024Pharma Firms Present Innovative Treatments for Major Diseases at CIIE
  • Page:2/39 Total number of articles:1152: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group